2022. DEMERGER, A PANACEA FOR CORPORATE PROBLEMS - A CASE STUDY ON CROMPTON GREAVES LIMITED. Journal of Pharmaceutical Negative Results. (Oct. 2022), 1507–1511. DOI:https://doi.org/10.47750/pnr.2022.13.S06.200.